MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.M

MYDECINE INNOVATIONS GROUP INC.

0.005CADR
0.0000.00%
At close at Jan 7, 18:21 UTC
CAD
No trades
See on Supercharts

MYCO fundamentals

Key facts

Market capitalization‪264.57 K‬CAD
Basic EPS (TTM)−0.27CAD
Founded2013
CEODavid Joshua Bartch
About

Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Ownership
‪‪26.46 M‬‬
Free Float shares
‪‪25.79 M‬‬ (97.46%)
Closely held shares
‪‪671.28 K‬‬ (2.54%)
Free Float shares
‪‪25.79 M‬‬ (97.46%)
Closely held shares
‪‪671.28 K‬‬ (2.54%)
Capital structure
Market cap
‪‪264.57 K‬‬
Debt
‪‪6.53 M‬‬
Cash & equivalents
‪‪60.17 K‬‬
Enterprise value
‪‪6.73 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪264.57 K‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24

Growth and Profitability

Company’s recent performance and margins

Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.00 M‬‬
‪‪−1.50 M‬‬
‪‪−1.00 M‬‬
‪‪−500.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−2.00 M‬‬
‪‪−1.50 M‬‬
‪‪−1.00 M‬‬
‪‪−500.00 K‬‬
‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
2021
2022
2023
2024
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬
Actual
Estimate
Earnings
Next:Mar 28
2021
2022
2023
2024
‪−6.00‬
‪−3.00‬
‪0.00‬
‪3.00‬
‪6.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

MYCO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪5.00 M‬‬
‪‪10.00 M‬‬
‪‪15.00 M‬‬
‪‪20.00 M‬‬
Assets
Liabilities